The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.
about
MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinomaMicroRNA expression and its implications for diagnosis and therapy of gallbladder cancerTumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma.The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.RETRACTED: Expression of microRNA-497 and its prognostic significance in human breast cancermiR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.MiR-195 affects cell migration and cell proliferation by down-regulating DIEXF in Hirschsprung's disease.ZNF367 inhibits cancer progression and is targeted by miR-195MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancerIncreased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.Systematic exploration of autonomous modules in noisy microRNA-target networks for testing the generality of the ceRNA hypothesisMicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer.MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1RUp-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition.Post-transcriptional regulation of BRCA1 through its coding sequence by the miR-15/107 group of miRNAs.miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients.Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions.The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 ExpressionAnalysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomasPAQR3: a novel tumor suppressor gene.Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinomamicroRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6.Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.
P2860
Q26779540-8FDADD6D-A743-48CB-9E64-5C671190A231Q26865667-54FED5D4-178D-4373-BB6B-B54C185B498CQ30543779-FF008866-244B-4042-ADFE-5CE8CD66FC63Q30993390-38474B8E-0C3F-4F0A-91DD-C5936A0683ABQ33556403-5FF29D79-1595-4723-910D-491E39C6F281Q33589261-66DB02F7-6870-4E84-8FAB-6ED637174CA2Q33685465-DC215F52-6499-4C63-B7CE-09D4D0051DA7Q33905930-BA6A680F-6F72-4BB7-9C1F-FA8A5969E576Q33928274-52764D11-E372-4C0A-BEF8-8688A8FD660BQ34334470-FF3AB79C-2B76-4398-95F4-3F495186A9B0Q34704989-393DF136-A935-40F7-AEA7-BC09350BC82CQ35131201-271D9416-E394-47F2-87FE-753D4EE1AB1FQ35144952-838BFC5E-5ACE-45FB-9385-A7669BE6B4B7Q35201080-6C2A8A6E-F93A-4A03-BFD8-BC6A0A4C1C68Q35227870-5FE50E2D-A87B-4D4C-9A01-3B84F5C43B15Q35632595-2CF3CB32-C9D6-4BB9-82BD-382BB8E23D4BQ35641383-80CD34B5-46F4-4685-B247-D65B6D338146Q35739550-7EB811D1-61CC-4579-9627-36173D6FD5AEQ35832399-02263542-B9AD-49A4-82F9-24759D988041Q35857110-3B5FC51F-D019-4ED3-B6E8-6E9809DE4086Q35884235-B55A8126-3A05-40BE-92B9-85A47FFD306AQ35955231-73138AF5-F208-44F5-BFA7-7497943E4176Q36012203-D79162E0-0CEB-485F-A1DC-67DC26BC5CDDQ36069168-110748BC-0280-4CAB-A455-49EE9053599BQ36071336-98695C7A-2443-421C-AA89-82EB95F4A020Q36089694-056E02A2-CB22-4391-B433-402BA5BB9828Q36091092-DA2A9C53-31C7-4F8B-8405-070613EC3DADQ36250590-429351A5-27DC-407B-AEA2-55A30C8FA8E6Q36367148-806F1346-4DBA-4050-AEE1-C50D925564A9Q36413483-A3E8BD56-6154-49E6-BCEA-0408F0800FF3Q36546506-9B1DDB13-3777-4ED4-913C-D1E858D0DE64Q36557358-886D7384-F117-431A-A178-1D6795B2EDBEQ36629563-E0053AF8-1518-445A-98EE-E9F83A1E3770Q36766747-B37E9941-F8BD-4ED6-9864-8538C0F47049Q36939787-92EC13D0-31F4-4350-87CC-EAA3B347F7E3Q36962575-E78FEF1E-8D0D-4E71-BD81-018EB7617E7AQ36968311-EF0996A9-0DF2-4C8C-B27E-474001E03BD8Q37291450-9867296C-3998-4C48-95DF-91B0AF229D1BQ37447873-1E147EF8-B090-4962-B731-B376BF038C1AQ37617262-0D4EE98D-AF3C-4BCD-A923-A881FA57A377
P2860
The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@ast
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@en
type
label
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@ast
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@en
prefLabel
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@ast
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
The tumor-suppressive miR-497- ...... s in hepatocellular carcinoma.
@en
P2093
Atsushi Niida
Johji Inazawa
Ken-ichi Kozaki
Kousuke Tanimoto
Mayuko Furuta
Satoru Miyano
Shigeki Arii
Shinji Tanaka
P2860
P304
P356
10.1371/JOURNAL.PONE.0060155
P407
P577
2013-03-27T00:00:00Z